Tegge Jonathan's most recent trade in InMed Pharmaceuticals Inc was a trade of 30,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | Tegge Jonathan | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 30,000 | 31,400 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Jonathan Tegge | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 1,400 | 1,400 | - | - | Employee Stock Option (Right to Buy) |